Lactonic sophorolipid–induced apoptosis in human HepG2 cells through the Caspase-3 pathway
- 13 February 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Applied Microbiology and Biotechnology
- Vol. 105 (5), 2033-2042
- https://doi.org/10.1007/s00253-020-11045-5
Abstract
Liver cancer, one of the most common types of cancer in the world, is the second leading cause of death for cancer patients. For liver cancer, there is an urgent need for an effective treatment with no or less toxic side effects. Lactonic sophorolipids (LSL), as a potential anticancer drug, has attracted wide attention of pharmaceutical researchers with its good biological activities. The effects of LSL and cell death inhibitors were measured by MTT test on HepG2 cells. Meanwhile, the morphology of the cells was observed under a microscope. The apoptosis rate was detected by flow cytometry, and the expression levels of enzyme activity of Caspase-3 and Caspase-9 were measured by detection kits. Meanwhile, mRNA levels of Apaf-1, Caspase-3, Bax, and Bcl-2 were measured by quantitative real-time RT-PCR; protein levels of Caspase-3, Cleaved Caspase-3, Bax, and Bcl-2 were measured by western blot. LSL can inhibit the proliferation of cells, and it is possible to induce apoptosis in cells. The HepG2 cells with LSL co-culture exhibited typical apoptotic morphology, and the expression levels of enzyme activity of Caspase-3 and Caspase-9 increased (P< 0.05). We also found that LSL increases cell apoptosis rate and regulates the expression of genes and proteins associated with apoptosis through the Caspase-3 pathway. These results indicate that LSL may be one of the potential drug candidates to inhibit the proliferation and induce apoptosis in HepG2 cells. Key points • LSL, which is of good biological activities such as anti-bacterium, virus elimination, and inflammatory response elimination, has been firstly used to intervene in vitro to investigate its effect on HepG2 cell proliferation. • LSL can inhibit the proliferation of cells, and it is possible to induce apoptosis in HepG2 cells through the Caspase-3 pathway. • The mechanism of LSL action on HepG2 cell proliferation was firstly also discussed, which provides a certain experimental reference for the clinical treatment of liver cancer. Graphical abstractKeywords
Funding Information
- China Scholarship Council (201908340044)
- Natural Science Foundation of Anhui Province (1808085MC71)
- Key project of support program for top talents of colleges and universities of Anhui Province department of education (gxgwfx2019027)
- Anhui Province Postdoctoral Science Foundation (2017B230)
This publication has 34 references indexed in Scilit:
- Characteristics of liver cancer stem cells and clinical correlationsCancer Letters, 2016
- Treatment of Liver CancerCold Spring Harbor Perspectives in Medicine, 2015
- Liver cancer: Approaching a personalized careJournal of Hepatology, 2015
- Development of novel sophorolipids with improved cytotoxic activity toward MDA‐MB‐231 breast cancer cellsJournal of Molecular Recognition, 2015
- Surface and biological activity of sophorolipid molecules produced by Wickerhamiella domercqiae var. sophorolipid CGMCC 1576Journal of Colloid and Interface Science, 2012
- Enhancement of Sophorolipid Production of Wickerhamiella domercqiae var. sophorolipid CGMCC 1576 by Low-Energy Ion Beam ImplantationApplied Biochemistry and Biotechnology, 2012
- Oridonin induces apoptosis in gastric cancer through Apaf-1, cytochrome c and caspase-3 signaling pathwayWorld Journal of Gastroenterology, 2012
- Effects of nitrogen sources on production and composition of sophorolipids by Wickerhamiella domercqiae var. sophorolipid CGMCC 1576Applied Microbiology and Biotechnology, 2011
- Differentiation-inducing ability of sophorolipids of oleic and linoleic acids using a glioma cell lineBiotechnology Journal, 2011
- Antitumor effect of matrine in human hepatoma G2 cells by inducing apoptosis and autophagyWorld Journal of Gastroenterology, 2010